Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-09-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Currently, highly pathogenic clade2.3.4.4b H5 avian influenza viruses are continuously circulating in wild birds in Belgium and the number of introduction in poultry farms has raised, increasing the contact opportunities with high viral concentrations. Several reports of suspected human infection have been made by different countries. In addition, the virus was detected in sick non-human mammals. The large circulation in wild birds thus represents an increase risk of spill-over to mammalian species, including humans, (by contact directly with wild birds, or via outbreaks in poultry). This increased opportunity for accidental spillover to new host species increases the chances for the avian virus to adapt to mammals, including humans.
Likewise, there have also been an increased number of human cases of swine influenza reported by several European countries. A pro-active surveillance aiming at also detecting asymptomatic infections would allow an early detection of transmission that could help to prevent a new pandemic.
As a piloting approach during this specific project, some dedicated sentinel networks among at-risk workers will be initiated: people in poultry farms involved with the management of outbreaks of highly pathogenic avian influenza; people working at bird (or more generally wild life) rehabilitation centres or poultry farms; veterinarians working in pig farms/slaughterhouses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Analysis of Seasonal Influenza - Viral Transmission and Evolution in the City of Basel, Switzerland
NCT03010007
Prospective System Analysis of the Seasonal Influenza Virus Transmissions and Evolution in the City of Basel Basel
NCT03451656
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers
NCT02459171
A Retrospective, Observational Registry of Participants With Avian Influenza Infection
NCT02743676
Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
NCT01617239
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Avian Influenza Outbreak Farms
People involved in outbreak management, ranging from poultry farm owners and their family to inspectors through veterinarians and cullers/cleaners, will be invited to take part in the study at the earliest step possible after outbreak detection. Self sampling by nasopharyngeal swab will be requested every 2 days during 2 weeks.
respiratory specimen
participants will perform self-sampling with a nasopharyngeal swab
serum
participants will be invited to get a blood sample taken by a general practitioner or to perform a self sampling of capillary blood
Poultry Farm Sentinel Network
People working in poultry farms and in contact with animals will be invited to join the cohort. Self sampling by nasopharyngeal swab will be requested every 2 weeks for the whole duration of the study.
anticipated: 15
respiratory specimen
participants will perform self-sampling with a nasopharyngeal swab
Wild bird/life Rehabilitation Centre Sentinel Network
People working in wild bird/life rehabilitation centers and in contact with animals will be invited to join the cohort. Self sampling by nasopharyngeal swab will be requested every 2 weeks for the whole duration of the study.
anticipated: 25
respiratory specimen
participants will perform self-sampling with a nasopharyngeal swab
Pig Industry Veterinarian Sentinel Network
Veterinarians working in the pig industry and in contact with animals will be invited to join the cohort. Self sampling by nasopharyngeal swab will be requested every 2 weeks for the whole duration of the study.
anticipated: 15
respiratory specimen
participants will perform self-sampling with a nasopharyngeal swab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
respiratory specimen
participants will perform self-sampling with a nasopharyngeal swab
serum
participants will be invited to get a blood sample taken by a general practitioner or to perform a self sampling of capillary blood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to have regular contacts with animals within job/activity framework
* being committed to take the regular samples
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sciensano
OTHER_GOV
Belgian Federal Public Service, Food Chain Safety and Environment
OTHER_GOV
Agentschap Zorg en Gezondheid
UNKNOWN
Cyril Barbezange
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cyril Barbezange
Head of Belgian National Influenza Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sciensano
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZOOIS-23-24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.